Income Statement Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 11:55:00 2026-06-05 EDT			5-day change	1st Jan Change
22.73 ^EUR	+1.56%		-0.61%	-2.19%

06-04	Wellspan Health and Royal Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland	CI
06-04	Philips, WellSpan Health Form Partnership Focused on AI and Imaging Technology	MT

41bb.A59fo5Ywf1TBoA48opM4EI4bctibZnuzEpauee3mxZI.QOkwwPllHT_z9GlXlqZ1XdktQK7iBBrRaNfiDZeVp_9wywrw7l0ME6PtTw

Published financial data: PHILIPS NV

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	17.16B	17.83B	18.17B	18.02B	17.83B
Total Revenues	17.16B	17.83B	18.17B	18.02B	17.83B
Cost of Goods Sold, Total	9.93B	10.63B	10.72B	10.25B	9.78B
Gross Profit	7.22B	7.19B	7.45B	7.77B	8.06B
Selling General & Admin Expenses, Total	4.72B	5.29B	5.15B	5.09B	4.99B
R&D Expenses	1.7B	1.97B	1.89B	1.75B	1.7B
Other Operating Expenses	-32M	20M	-12M	-1M	-60M
Other Operating Expenses, Total	6.4B	7.28B	7.03B	6.83B	6.63B
Operating Income	825M	-85M	417M	939M	1.43B
Interest Expense, Total	-152M	-234M	-285M	-268M	-271M
Interest And Investment Income	20M	28M	48M	82M	86M
Net Interest Expenses	-132M	-206M	-237M	-186M	-185M
Income (Loss) On Equity Invest.	-4M	-2M	-98M	-124M	-9M
Currency Exchange Gains (Loss)	-	9M	-23M	-7M	-6M
Other Non Operating Income (Expenses)	5M	-3M	-7M	-54M	1M
EBT, Excl. Unusual Items	694M	-287M	52M	568M	1.23B
Restructuring Charges	-	-134M	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-15M	-1.36B	-8M	-	-
Gain (Loss) On Sale Of Investments	95M	9M	-26M	-16M	-26M
Gain (Loss) On Sale Of Assets	-56M	6M	61M	16M	-24M
Asset Writedown	-55M	-	-	-	-
Insurance Settlements	-	-	-	538M	-
Legal Settlements	-	-60M	-606M	-984M	-
Other Unusual Items	-154M	92M	-	-	-
EBT, Incl. Unusual Items	509M	-1.73B	-527M	122M	1.18B
Income Tax Expense	-103M	-113M	-73M	963M	282M
Earnings From Continuing Operations	612M	-1.62B	-454M	-841M	900M
Earnings Of Discontinued Operations	2.71B	13M	-10M	142M	-4M
Net Income to Company	3.32B	-1.6B	-464M	-699M	896M
Minority Interest	-4M	-3M	-2M	-3M	-1M
Net Income - (IS)	3.32B	-1.61B	-466M	-702M	895M
Net Income to Common Incl Extra Items	3.32B	-1.61B	-466M	-702M	895M
Net Income to Common Excl. Extra Items	608M	-1.62B	-456M	-844M	899M
Per Share Items
Net EPS - Basic	3.48	-1.73	-0.5	-0.75	0.94
Basic EPS - Continuing Operations	0.64	-1.75	-0.49	-0.9	0.95
Basic Weighted Average Shares Outstanding	953M	929M	925M	933M	948M
Net EPS - Diluted	3.46	-1.73	-0.51	-0.75	0.93
Diluted EPS - Continuing Operations	0.64	-1.75	-0.5	-0.9	0.93
Diluted Weighted Average Shares Outstanding	958M	929M	925M	933M	963M
Normalized Basic EPS	0.45	-0.2	0.03	0.38	0.81
Normalized Diluted EPS	0.45	-0.2	0.03	0.38	0.8
Dividend Per Share	0.81	-	-	0.85	0.85
Payout Ratio	14.52	-25.62	-0.43	-0.14	36.65
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.47B	669M	1.13B	1.59B	2.02B
EBITA	1.09B	222M	707M	1.19B	1.64B
EBIT	825M	-85M	417M	939M	1.43B
EBITDAR	1.49B	708M	1.18B	1.65B	2.06B
Effective Tax Rate - (Ratio)	-20.24	6.53	13.85	789.34	23.86
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	298M	97M	201M	140M	305M
Deferred Domestic Taxes	-	-	-	-	-
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-401M	-210M	-274M	823M	-24M
Normalized Net Income	430M	-182M	30.5M	352M	769M
Interest on Long-Term Debt	5M	25M	27M	37M	38M
Non-Cash Pension Expense	36M	49M	46M	43M	71M
Supplemental Operating Expense Items
Advertising Expense	752M	739M	700M	791M	794M
Selling and Marketing Expenses	4.12B	4.61B	4.52B	4.49B	4.34B
General and Administrative Expenses	599M	671M	608M	582M	628M
Research And Development Expense From Footnotes	1.98B	2.29B	2.02B	2.22B	2.02B
Net Rental Expense, Total	19M	39M	51M	54M	43M
Imputed Operating Lease Interest Expense	3.32M	9.62M	14.64M	15.11M	11.86M
Imputed Operating Lease Depreciation	15.68M	29.38M	36.36M	38.89M	31.14M
Stock-Based Comp., Other (Total)	116M	104M	97M	104M	148M
Total Stock-Based Compensation	116M	104M	97M	104M	148M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.3B	1.17B	1.87B	2.4B	2.79B
Short Term Investments	2M	11M	3M	2M	-
Total Cash And Short Term Investments	2.3B	1.18B	1.87B	2.4B	2.79B
Accounts Receivable, Total	3.85B	4.12B	3.84B	3.86B	3.69B
Other Receivables	439M	529M	414M	253M	252M
Notes Receivable	-	-	-	-	-
Total Receivables	4.29B	4.65B	4.26B	4.11B	3.94B
Inventory	3.45B	4.05B	3.49B	3.2B	2.87B
Prepaid Expenses	172M	174M	197M	238M	180M
Other Current Assets, Total	132M	200M	124M	69M	149M
Total Current Assets	10.35B	10.26B	9.94B	10.02B	9.93B
Gross Property Plant And Equipment	6B	6.25B	6.16B	6.44B	5.92B
Accumulated Depreciation	-3.3B	-3.61B	-3.68B	-3.99B	-3.71B
Net Property Plant And Equipment	2.7B	2.64B	2.48B	2.45B	2.22B
Long-term Investments	1.06B	1.2B	1B	888M	852M
Goodwill	10.64B	10.24B	9.88B	10.38B	9.27B
Other Intangibles, Total	3.05B	3.13B	2.85B	2.56B	2.07B
Deferred Tax Assets Long-Term	2.22B	2.45B	2.63B	1.92B	1.77B
Deferred Charges Long-Term	598M	393M	336M	418M	501M
Other Long-Term Assets, Total	356M	381M	290M	333M	330M
Total Assets	30.96B	30.69B	29.41B	28.98B	26.94B
Liabilities
Accounts Payable, Total	1.87B	1.97B	1.92B	1.83B	1.93B
Accrued Expenses, Total	2.28B	1.97B	2.22B	1.93B	1.9B
Short-term Borrowings	47M	89M	122M	92M	52M
Current Portion of Long-Term Debt	202M	612M	321M	215M	892M
Current Portion of Leases	257M	230M	211M	219M	207M
Current Income Taxes Payable	128M	40M	83M	71M	174M
Unearned Revenue Current, Total	1.49B	1.7B	1.81B	1.7B	1.49B
Other Current Liabilities	1.17B	1.32B	1.6B	2.09B	862M
Total Current Liabilities	7.45B	7.93B	8.29B	8.15B	7.51B
Long-Term Debt	5.51B	6.42B	6.17B	6.26B	6.18B
Long-Term Leases	963M	852M	864M	854M	757M
Unearned Revenue Non Current	446M	515M	469M	431M	458M
Pension & Other Post Retirement Benefits	659M	546M	558M	560M	520M
Deferred Tax Liability Non Current	83M	91M	71M	81M	93M
Other Non Current Liabilities	1.38B	1.05B	925M	602M	441M
Total Liabilities	16.49B	17.4B	17.34B	16.93B	15.96B
Common Stock, Total	177M	178M	183M	188M	193M
Additional Paid In Capital	4.65B	5.02B	5.83B	6.65B	7.21B
Retained Earnings	9.34B	6.83B	5.4B	3.65B	3.58B
Treasury Stock	-476M	-275M	-262M	-411M	-298M
Comprehensive Income and Other	747M	1.49B	879M	1.92B	274M
Total Common Equity	14.44B	13.25B	12.03B	12.01B	10.96B
Minority Interest	36M	34M	33M	37M	32M
Total Equity	14.47B	13.28B	12.06B	12.04B	10.99B
Total Liabilities And Equity	30.96B	30.69B	29.41B	28.98B	26.94B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	917M	929M	914M	925M	951M
ECS Total Common Shares Outstanding	917M	929M	914M	925M	951M
Book Value / Share	15.75	14.27	13.16	12.98	11.52
Tangible Book Value	749M	-122M	-702M	-941M	-382M
Tangible Book Value Per Share	0.82	-0.13	-0.77	-1.02	-0.4
Total Debt	6.98B	8.2B	7.69B	7.64B	8.08B
Net Debt	4.67B	7.02B	5.82B	5.24B	5.29B
Debt Equivalent of Unfunded Proj. Benefit Obligation	590M	499M	516M	509M	518M
Debt Equivalent Oper. Leases	152M	312M	408M	432M	344M
Minority Interest, Total (Incl. Fin. Div)	36M	34M	33M	37M	32M
Equity Method Investments, Total	426M	537M	381M	257M	148M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.14B	1.54B	1.31B	1.34B	1.18B
Inventories - Work In Process, Total	646M	648M	552M	414M	408M
Inventories - Finished Goods, Total	1.66B	1.86B	1.63B	1.44B	1.29B
Land - (BS)	39M	1.14B	1.11B	1.15B	1.1B
Buildings, Total	1.06B	-	-	-	-
Machinery, Total	2.97B	3.23B	3.13B	3.32B	2.96B
Full Time Employees	78.19K	77.23K	69.66K	62.63K	61.08K
Accumulated Allowance for Doubtful Accounts (Supple)	190M	226M	216M	245M	193M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3.32B	-1.61B	-466M	-702M	895M
Depreciation & Amortization - CF	629M	661M	621M	608M	563M
Amortization of Goodwill and Intangible Assets - (CF)	267M	307M	290M	249M	212M
Depreciation & Amortization, Total	896M	968M	911M	857M	775M
Amortization of Deferred Charges, Total - (CF)	372M	307M	266M	257M	252M
(Gain) Loss From Sale Of Asset	55M	-115M	-71M	-19M	23M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	70M	1.68B	92M	276M	98M
(Income) Loss On Equity Investments - (CF)	4M	112M	107M	126M	9M
Stock-Based Compensation (CF)	108M	95M	88M	96M	141M
Net Cash From Discontinued Operations	3.4B	-12M	123M	-13M	-10M
Other Operating Activities, Total	-3.21B	-472M	-55M	772M	211M
Change In Accounts Receivable	-39M	-342M	298M	-1M	-9M
Change In Inventories	-581M	-572M	257M	230M	-115M
Change In Accounts Payable	219M	52M	358M	-583M	97M
Change in Other Net Operating Assets	414M	-282M	351M	260M	-1.2B
Cash from Operations	5.03B	-185M	2.26B	1.56B	1.16B
Capital Expenditure	-397M	-444M	-345M	-317M	-269M
Sale of Property, Plant, and Equipment	33M	18M	90M	13M	9M
Cash Acquisitions	-3.1B	-712M	-73M	-8M	-3M
Divestitures	107M	124M	80M	126M	-22M
Sale (Purchase) of Intangible assets	-366M	-362M	-299M	-359M	-399M
Investment in Marketable and Equity Securities, Total	0	-38M	-44M	-66M	15M
Other Investing Activities, Total	49M	-73M	-45M	38M	-68M
Cash from Investing	-3.67B	-1.49B	-636M	-573M	-737M
Short Term Debt Issued, Total	-	47M	29M	-	-
Long-Term Debt Issued, Total	76M	2.52B	544M	710M	1.06B
Total Debt Issued	76M	2.56B	573M	710M	1.06B
Short Term Debt Repaid, Total	-25M	-	-	-30M	-24M
Long-Term Debt Repaid, Total	-302M	-1.47B	-754M	-763M	-609M
Total Debt Repaid	-327M	-1.47B	-754M	-793M	-633M
Issuance of Common Stock	23M	12M	-	-	13M
Repurchase of Common Stock	-1.64B	-187M	-662M	-411M	-
Common Dividends Paid	-482M	-412M	-2M	-1M	-328M
Common & Preferred Stock Dividends Paid	-482M	-412M	-2M	-1M	-328M
Other Financing Activities, Total	-1M	-4M	-3M	-1M	-2M
Cash from Financing	-2.35B	500M	-848M	-496M	107M
Foreign Exchange Rate Adjustments	65M	41M	-79M	45M	-139M
Miscellaneous Cash Flow Adjustments	1M	-	1M	-	-
Net Change in Cash	-921M	-1.13B	697M	532M	393M
Supplemental Items
Cash Interest Paid	151M	205M	250M	261M	253M
Cash Income Tax Paid (Refund)	249M	333M	152M	173M	213M
Levered Free Cash Flow	1.44B	-601M	2.35B	1.4B	453M
Unlevered Free Cash Flow	1.53B	-455M	2.53B	1.56B	622M
Change In Net Working Capital	-397M	975M	-1.64B	-436M	779M
Net Debt Issued / Repaid	-251M	1.09B	-181M	-83M	424M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.76	-0.17	0.87	2.01	3.2
Return on Total Capital	2.56	-0.25	1.26	2.98	4.62
Return On Equity %	4.64	-11.66	-3.58	-6.98	7.82
Return on Common Equity	4.62	-11.71	-3.61	-7.02	7.83
Margin Analysis
Gross Profit Margin %	42.1	40.35	40.99	43.13	45.18
SG&A Margin	27.54	29.67	28.36	28.23	27.96
EBITDA Margin %	8.56	3.75	6.2	8.85	11.3
EBITA Margin %	6.37	1.25	3.89	6.59	9.21
EBIT Margin %	4.81	-0.48	2.3	5.21	8.02
Income From Continuing Operations Margin %	3.57	-9.08	-2.5	-4.67	5.05
Net Income Margin %	19.35	-9.02	-2.56	-3.9	5.02
Net Avail. For Common Margin %	3.54	-9.09	-2.51	-4.68	5.04
Normalized Net Income Margin	2.5	-1.02	0.17	1.95	4.31
Levered Free Cash Flow Margin	8.39	-3.37	12.94	7.75	2.54
Unlevered Free Cash Flow Margin	8.94	-2.55	13.92	8.68	3.49
Asset Turnover
Asset Turnover	0.58	0.58	0.6	0.62	0.64
Fixed Assets Turnover	6.38	6.68	7.1	7.3	7.64
Receivables Turnover (Average Receivables)	4.29	4.47	4.56	4.68	4.72
Inventory Turnover (Average Inventory)	3.08	2.84	2.84	3.06	3.22
Short Term Liquidity
Current Ratio	1.39	1.29	1.2	1.23	1.32
Quick Ratio	0.88	0.74	0.74	0.8	0.9
Operating Cash Flow to Current Liabilities	0.68	-0.02	0.27	0.19	0.15
Days Sales Outstanding (Average Receivables)	85.17	81.62	80.01	78.22	77.26
Days Outstanding Inventory (Average Inventory)	118.38	128.71	128.35	119.45	113.28
Average Days Payable Outstanding	70.1	62.39	69.76	68.88	72.57
Cash Conversion Cycle (Average Days)	133.44	147.94	138.6	128.79	117.97
Long Term Solvency
Total Debt/Equity	48.22	61.74	63.75	63.43	73.57
Total Debt / Total Capital	32.53	38.17	38.93	38.81	42.39
LT Debt/Equity	44.72	54.73	58.33	59.06	63.1
Long-Term Debt / Total Capital	30.17	33.84	35.62	36.14	36.35
Total Liabilities / Total Assets	53.25	56.72	58.98	58.44	59.22
EBIT / Interest Expense	5.43	-0.36	1.46	3.5	5.28
EBITDA / Interest Expense	11.32	3.77	4.66	6.7	8.14
(EBITDA - Capex) / Interest Expense	8.71	1.88	3.45	5.52	7.15
Total Debt / EBITDA	4.06	9.29	5.79	4.25	3.67
Net Debt / EBITDA	2.72	7.95	4.38	2.92	2.4
Total Debt / (EBITDA - Capex)	5.27	18.68	7.82	5.16	4.17
Net Debt / (EBITDA - Capex)	3.53	15.99	5.92	3.54	2.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.91	3.91	1.92	-0.81	-1.04
Gross Profit, 1 Yr. Growth %	-9.14	-0.4	3.53	4.36	3.67
EBITDA, 1 Yr. Growth %	-39.47	-53.15	68.46	41.44	26.47
EBITA, 1 Yr. Growth %	-46.1	-79.31	218.47	68.03	38.3
EBIT, 1 Yr. Growth %	-52.61	-110.51	-590.59	125.18	52.4
Earnings From Cont. Operations, 1 Yr. Growth %	-38.74	-364.38	-71.94	85.24	-207.02
Net Income, 1 Yr. Growth %	179.61	-148.45	-71.02	50.64	-227.49
Normalized Net Income, 1 Yr. Growth %	-55.87	-143.45	-116.72	1.05K	118.47
Diluted EPS Before Extra, 1 Yr. Growth %	-37.96	-374.61	-71.59	88.05	-202.85
Accounts Receivable, 1 Yr. Growth %	-7.41	7.14	-6.84	0.49	-4.56
Inventory, 1 Yr. Growth %	15.27	17.36	-13.78	-8.39	-10.26
Net Property, Plant and Equip., 1 Yr. Growth %	0.63	-2.26	-5.88	-1.25	-9.58
Total Assets, 1 Yr. Growth %	11.72	-0.88	-4.18	-1.46	-7.01
Tangible Book Value, 1 Yr. Growth %	-49.39	-116.27	475.41	34.05	-59.4
Common Equity, 1 Yr. Growth %	21.63	-8.24	-9.22	-0.18	-8.74
Cash From Operations, 1 Yr. Growth %	90.61	-103.68	-1.32K	-31.12	-25.32
Capital Expenditures, 1 Yr. Growth %	-18.14	11.84	-22.3	-8.12	-15.14
Levered Free Cash Flow, 1 Yr. Growth %	-11.26	-145.14	-490.85	-41	-67.54
Unlevered Free Cash Flow, 1 Yr. Growth %	-10.89	-131.84	-655.59	-38.11	-60.18
Dividend Per Share, 1 Yr. Growth %	0	-	-	-	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.03	1.47	2.91	0.54	-0.93
Gross Profit, 2 Yr. CAGR %	-4.67	-4.65	1.93	3.95	4.01
EBITDA, 2 Yr. CAGR %	-25.18	-50.7	-12.26	34.05	33.69
EBITA, 2 Yr. CAGR %	-26.37	-67.19	-7.98	159.81	52.34
EBIT, 2 Yr. CAGR %	-30.74	-77.54	-9.84	124.08	85.03
Earnings From Cont. Operations, 2 Yr. CAGR %	-21.34	27.26	-13.87	-27.9	40.8
Net Income, 2 Yr. CAGR %	68.64	16.39	-62.53	-33.93	38.59
Normalized Net Income, 2 Yr. CAGR %	-34.38	-55.96	-63.95	19.59	402.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-20.49	30.53	-11.61	-27.13	39.07
Accounts Receivable, 2 Yr. CAGR %	-7.79	-0.4	-0.09	-3.24	-2.04
Inventory, 2 Yr. CAGR %	11.54	16.31	0.59	-11.13	-9.33
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.96	-0.82	-4.08	-3.59	-5.51
Total Assets, 2 Yr. CAGR %	7.05	5.23	-2.54	-2.83	-4.28
Tangible Book Value, 2 Yr. CAGR %	-16.29	-71.29	-3.25	177.72	-26.23
Common Equity, 2 Yr. CAGR %	7.06	5.65	-8.73	-4.81	-4.56
Cash From Operations, 2 Yr. CAGR %	62.27	-73.53	-33	190.01	-28.28
Capital Expenditures, 2 Yr. CAGR %	-9.62	-4.32	-6.78	-15.5	-11.7
Levered Free Cash Flow, 2 Yr. CAGR %	48.67	-40.55	34.72	105	-56.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	42.15	-49.82	34.75	185.58	-50.39
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.81	1.3	1.62	1.65	0.01
Gross Profit, 3 Yr. CAGR %	-5.87	-3.27	-1.99	2.74	3.85
EBITDA, 3 Yr. CAGR %	-18.86	-36.59	-25.74	2.88	31.48
EBITA, 3 Yr. CAGR %	-22.12	-52.05	-30.01	12.47	110.56
EBIT, 3 Yr. CAGR %	-25.12	-63.3	-37.22	22.33	97.06
Earnings From Cont. Operations, 3 Yr. CAGR %	-22.41	17.83	-23.12	11.18	-17.76
Net Income, 3 Yr. CAGR %	44.94	11.28	-26.78	-40.42	-17.74
Normalized Net Income, 3 Yr. CAGR %	-27.48	-43.26	-68.11	14.46	46.19
Diluted EPS Before Extra, 3 Yr. CAGR %	-21.21	20.18	-21.5	12.53	-18.26
Accounts Receivable, 3 Yr. CAGR %	0.38	-3.06	-2.59	0.1	-3.66
Inventory, 3 Yr. CAGR %	8.86	13.45	5.26	-2.5	-10.84
Net Property, Plant and Equip., 3 Yr. CAGR %	21.39	-2.73	-2.54	-3.15	-5.63
Total Assets, 3 Yr. CAGR %	5.97	4.34	2	-2.18	-4.24
Tangible Book Value, 3 Yr. CAGR %	6.73	-51.49	-22.01	7.86	46.3
Common Equity, 3 Yr. CAGR %	6.1	1.7	0.44	-5.97	-6.14
Cash From Operations, 3 Yr. CAGR %	27.51	-54.08	-5.06	-32.38	84.51
Capital Expenditures, 3 Yr. CAGR %	-2.02	-2.97	-10.73	-7.23	-15.38
Levered Free Cash Flow, 3 Yr. CAGR %	-17.44	-2.6	11.37	2.57	10.86
Unlevered Free Cash Flow, 3 Yr. CAGR %	-16.76	-15.67	11.85	3.96	48.03
Dividend Per Share, 3 Yr. CAGR %	0.67	-	-	1.75	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.31	0.05	0.05	1	0.59
Gross Profit, 5 Yr. CAGR %	-1.93	-2.73	-2.97	-0.44	0.37
EBITDA, 5 Yr. CAGR %	-9.08	-22.85	-16.34	-9.49	-6.03
EBITA, 5 Yr. CAGR %	-10.78	-35.63	-21.1	-10.02	-4.44
EBIT, 5 Yr. CAGR %	-13.34	-45.38	-26.66	-11.4	-3.22
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.93	9.5	-19.1	-3.19	-2.07
Net Income, 5 Yr. CAGR %	18.04	-0.6	-15.63	-9.67	-5.49
Normalized Net Income, 5 Yr. CAGR %	-13.46	-25.8	-51.42	-18.82	-3.94
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.25	16.95	-17.54	-2.11	-1.93
Accounts Receivable, 5 Yr. CAGR %	-6.29	1.08	0.19	-3.13	-2.37
Inventory, 5 Yr. CAGR %	0.34	11.47	5.48	2.89	-0.84
Net Property, Plant and Equip., 5 Yr. CAGR %	6.43	12.7	10.47	-3.07	-3.74
Total Assets, 5 Yr. CAGR %	-0.82	3.92	2.48	1.41	-0.56
Tangible Book Value, 5 Yr. CAGR %	3.42	-39.71	2.65	-2.52	-23.73
Common Equity, 5 Yr. CAGR %	2.85	2	-0.1	-0.96	-1.59
Cash From Operations, 5 Yr. CAGR %	8.67	-42.46	-1.42	-4.03	-15.14
Capital Expenditures, 5 Yr. CAGR %	1.98	1.12	-3.95	-8.19	-11.12
Levered Free Cash Flow, 5 Yr. CAGR %	6.69	-21.64	-1.66	16.51	-23.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.6	-26.7	-1	15.57	-19.2
Dividend Per Share, 5 Yr. CAGR %	1.63	-	-	-	1.05